Perbedaan Panca Global Kapital Tbk. dan Organon Pharma Indonesia Tbk.: Panca Global Kapital Tbk. diperdagangkan di Rp130 (kapitalisasi pasar 487,35 M, volume 24 jam 11,11 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Panca Global Kapital Tbk. jauh lebih besar — sekitar 4,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PEGE | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 487,35 M | 104,4 M |
Volume | 11,11 jt | — |
Lot | 111,15 rb | — |
Perputaran | 1,42 M | — |
Harga Rata-rata | 127,8 | — |
Nilai Transaksi | 1,42 M | — |
Harga Ekuilibrium Indikatif | 130 | — |
Volume Ekuilibrium Indikatif | 1,46 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Panca Global Securities Tbk. (the Company) was established based on notarial deed No. 20 dated August 13th, 1999 of Fathiah Helmi, S.H., notary in Jakarta. The company's articles of association has been amended several times, and the latest amended on August 30, 2004 concerning company's plan for public offering. The company divides business into 2 divisions, stock brokerage and investment management division.
Selengkapnya di halaman PEGE →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →